Literature DB >> 28749056

On Legalizing Physician-Assisted Death for Dementia.

Rebecca Dresser.   

Abstract

Last November, soon after Colorado became the latest state to authorize physician-assisted suicide, National Public Radio's The Diane Rehm Show devoted a segment to legalization of "physician assistance in dying," a label that refers to both physician-assisted suicide and voluntary active euthanasia. Although the segment initially focused on PAD in the context of terminal illness in general, it wasn't long before PAD's potential application to dementia patients came up. A caller said that her mother had Alzheimer's disease and was being cared for at great expense. Suspecting that she will suffer the same fate, the caller reported that she had included in her will "my specific request that if I should be diagnosed, and it is legal to do so, I would like to opt out of a life and many years of suffering." A few countries, such as the Netherlands and Belgium, already allow PAD for dementia in certain circumstances. It wouldn't be surprising to see a U.S. legalization effort in the coming years.
© 2017 The Hastings Center.

Entities:  

Mesh:

Year:  2017        PMID: 28749056     DOI: 10.1002/hast.731

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  3 in total

1.  Advance euthanasia directives: a controversial case and its ethical implications.

Authors:  David Gibbes Miller; Rebecca Dresser; Scott Y H Kim
Journal:  J Med Ethics       Date:  2018-03-03       Impact factor: 2.903

2.  Clinical Considerations in Physician-Assisted Death for Probable Alzheimer's Disease: Decision-Making Capacity, Anosognosia, and Suffering.

Authors:  Jaime D Mondragón; Latife Salame; Arnoldo Kraus; Peter Paul De Deyn
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2019-06-18

3.  Bioethical implications of end-of-life decision-making in patients with dementia: a tale of two societies.

Authors:  Jaime D Mondragón; Latife Salame-Khouri; Arnoldo S Kraus-Weisman; Peter P De Deyn
Journal:  Monash Bioeth Rev       Date:  2020-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.